Literature DB >> 31276606

Pay for performance for hospitals.

Tim Mathes1, Dawid Pieper, Johannes Morche, Stephanie Polus, Thomas Jaschinski, Michaela Eikermann.   

Abstract

BACKGROUND: Pay-for-Performance (P4P) is a payment model that rewards health care providers for meeting pre-defined targets for quality indicators or efficacy parameters to increase the quality or efficacy of care.
OBJECTIVES: Our objective was to assess the impact of P4P for in-hospital delivered health care on the quality of care, resource use and equity. Our objective was not only to answer the question whether P4P works in general (simple perspective) but to provide a comprehensive and detailed overview of P4P with a focus on analyzing the intervention components, the context factors and their interrelation (more complex perspective). SEARCH
METHODS: We searched CENTRAL, MEDLINE, Embase, three other databases and two trial registers on 27 June 2018. In addition, we searched conference proceedings, gray literature and web pages of relevant health care institutions, contacted experts in the field, conducted cited reference searches and performed cross-checks of included references and systematic reviews on the same topic. SELECTION CRITERIA: We included randomized trials, cluster randomized trials, non-randomized clustered trials, controlled before-after studies, interrupted time series and repeated measures studies that analyzed hospitals, hospital units or groups of hospitals and that compared any kind of P4P to a basic payment scheme (e.g. capitation) without P4P. Studies had to analyze at least one of the following outcomes to be eligible: patient outcomes; quality of care; utilization, coverage or access; resource use, costs and cost shifting; healthcare provider outcomes; equity; adverse effects or harms. DATA COLLECTION AND ANALYSIS: Two review authors independently screened all citations for inclusion, extracted study data and assessed risk of bias for each included study. Study characteristics were extracted by one reviewer and verified by a second.We did not perform meta-analysis because the included studies were too heterogenous regarding hospital characteristics, the design of the P4P programs and study design. Instead we present a structured narrative synthesis considering the complexity as well as the context/setting of the intervention. We assessed the certainty of evidence using the GRADE approach and present the results narratively in 'Summary of findings' tables. MAIN
RESULTS: We included 27 studies (20 CBA, 7 ITS) on six different P4P programs. Studies analyzed between 10 and 4267 centers. All P4P programs targeted acute or emergency physical conditions and compared a capitation-based payment scheme without P4P to the same capitation-based payment scheme combined with a P4P add-on. Two P4P program used rewards or penalties; one used first rewards and than penalties; two used penalties only and one used rewards only. Four P4P programs were established and evaluated in the USA, one in England and one in France.Most studies showed no difference or a very small effect in favor of the P4P program. The impact of each P4P program was as follows.Premier Hospital Quality Incentive Demonstration Program: It is uncertain whether this program, which used rewards for some hospitals and penalties for others, has an impact on mortality, adverse clinical events, quality of care, equity or resource use as the certainty of the evidence was very low.Value-Based Purchasing Program: It is uncertain whether this program, which used rewards for some hospitals and penalties for others, has an impact on mortality, adverse clinical events or quality of care as the certainty of the evidence was very low. Equity and resource use outcomes were not reported in the studies, which evaluated this program.Non-payment for Hospital-Acquired Conditions Program: It is uncertain whether this penalty-based program has an impact on adverse clinical events as the certainty of the evidence was very low. Mortality, quality of care, equity and resource use outcomes were not reported in the studies, which evaluated this program.Hospital Readmissions Reduction Program: None of the studies that examined this penalty-based program reported mortality, adverse clinical events, quality of care (process quality score), equity or resource use outcomes.Advancing Quality Program: It is uncertain whether this reward-/penalty-based program has an impact on mortality as the certainty of the evidence was very low. Adverse clinical events, quality of care, equity and resource use outcomes were not reported in any study.Financial Incentive to Quality Improvement Program: It is uncertain whether this reward-based program has an impact on quality of care, as the certainty of the evidence was very low. Mortality, adverse clinical events, equity and resource use outcomes were not reported in any study.Subgroup analysis (analysis of modifying design and context factors)Analysis of P4P design factors provides some hints that non-payments compared to additional payments and payments for quality attainment (e.g. falling below specified mortality threshold) compared to quality improvement (e.g. reduction of mortality by specified percent points within one year) may have a stronger impact on performance. AUTHORS'
CONCLUSIONS: It is uncertain whether P4P, compared to capitation-based payments without P4P for hospitals, has an impact on patient outcomes, quality of care, equity or resource use as the certainty of the evidence was very low (or we found no studies on the outcome) for all P4P programs. The effects on patient outcomes of P4P in hospitals were at most small, regardless of design factors and context/setting. It seems that with additional payments only small short-term but non-sustainable effects can be achieved. Non-payments seem to be slightly more effective than bonuses and payments for quality attainment seem to be slightly more effective than payments for quality improvement.

Entities:  

Mesh:

Year:  2019        PMID: 31276606      PMCID: PMC6611555          DOI: 10.1002/14651858.CD011156.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  80 in total

1.  Incentives and provider payment methods.

Authors:  H Barnum; J Kutzin; H Saxenian
Journal:  Int J Health Plann Manage       Date:  1995 Jan-Mar

Review 2.  Does pay-for-performance improve the quality of health care?

Authors:  Laura A Petersen; LeChauncy D Woodard; Tracy Urech; Christina Daw; Supicha Sookanan
Journal:  Ann Intern Med       Date:  2006-08-15       Impact factor: 25.391

3.  Public reporting and pay for performance in hospital quality improvement.

Authors:  Peter K Lindenauer; Denise Remus; Sheila Roman; Michael B Rothberg; Evan M Benjamin; Allen Ma; Dale W Bratzler
Journal:  N Engl J Med       Date:  2007-01-26       Impact factor: 91.245

4.  Changes in Hospital Quality Associated with Hospital Value-Based Purchasing.

Authors:  Andrew M Ryan; Sam Krinsky; Kristin A Maurer; Justin B Dimick
Journal:  N Engl J Med       Date:  2017-06-15       Impact factor: 91.245

5.  Paying for outcomes, not performance: lessons from the Medicare Inpatient Prospective Payment System.

Authors:  Richard F Averill; John S Hughes; Norbert I Goldfield
Journal:  Jt Comm J Qual Patient Saf       Date:  2011-04

6.  The effect of pay-for-performance in hospitals: lessons for quality improvement.

Authors:  Rachel M Werner; Jonathan T Kolstad; Elizabeth A Stuart; Daniel Polsky
Journal:  Health Aff (Millwood)       Date:  2011-04       Impact factor: 6.301

7.  Hospital-Acquired Pressure Ulcers at Academic Medical Centers in the United States, 2008-2012: Tracking Changes Since the CMS Nonpayment Policy.

Authors:  William V Padula; Mary Beth F Makic; Heidi L Wald; Jonathan D Campbell; Kavita V Nair; Manish K Mishra; Robert J Valuck
Journal:  Jt Comm J Qual Patient Saf       Date:  2015-06

8.  The impact of pay-for-performance on quality of care for minority patients.

Authors:  Arnold M Epstein; Ashish K Jha; E John Orav
Journal:  Am J Manag Care       Date:  2014-10-01       Impact factor: 2.229

9.  The effect of financial incentives on hospitals that serve poor patients.

Authors:  Ashish K Jha; E John Orav; Arnold M Epstein
Journal:  Ann Intern Med       Date:  2010-09-07       Impact factor: 25.391

10.  Reduced mortality with hospital pay for performance in England.

Authors:  Matt Sutton; Silviya Nikolova; Ruth Boaden; Helen Lester; Ruth McDonald; Martin Roland
Journal:  N Engl J Med       Date:  2012-11-08       Impact factor: 91.245

View more
  6 in total

1.  Assessing Taiwan's pay-for-performance program for diabetes care: a cost-benefit net value approach.

Authors:  Jui-Fen Rachel Lu; Ying Isabel Chen; Karen Eggleston; Chih-Hung Chen; Brian Chen
Journal:  Eur J Health Econ       Date:  2022-08-22

Review 2.  Hospital funding reforms in Canada: a narrative review of Ontario and Quebec strategies.

Authors:  Maude Laberge; Francesca Katherine Brundisini; Myriam Champagne; Imtiaz Daniel
Journal:  Health Res Policy Syst       Date:  2022-06-27

3.  Effect of Time of Daily Data Collection on the Calculation of Catheter-associated Urinary Tract Infection Rates.

Authors:  Lane F Donnelly; Matthew Wood; Ling Loh; Natasa Tekic; Andrew Y Shin; David Scheinker
Journal:  Pediatr Qual Saf       Date:  2021-08-26

4.  Leveraging financial incentives and behavioural economics to engage physicians in achieving quality-improvement process measures.

Authors:  Husein Moloo; Tyler Lamb; Sudhir Sundaresan; Kednapa Thavorn; Caolan Walsh; Reilly Musselman; Alan Forster
Journal:  Can J Surg       Date:  2022-04-27       Impact factor: 2.840

5.  Payment methods for healthcare providers working in outpatient healthcare settings.

Authors:  Liying Jia; Qingyue Meng; Anthony Scott; Beibei Yuan; Lu Zhang
Journal:  Cochrane Database Syst Rev       Date:  2021-01-20

6.  Effect of monitoring surgical outcomes using control charts to reduce major adverse events in patients: cluster randomised trial.

Authors:  Antoine Duclos; François Chollet; Léa Pascal; Hector Ormando; Matthew J Carty; Stéphanie Polazzi; Jean-Christophe Lifante
Journal:  BMJ       Date:  2020-11-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.